© 2020 MJH Life Sciences and Formulary Watch. All rights reserved.
FDA
Popular HIV-1 med successful, particularly in order adults
July 07, 2020
Gilead will present new data on virologic suppression in adults 65 years and older at AIDS 2020: Virtual this week.
Pharma maker seeks fast approval of lymphoma treatment
June 23, 2020
Investigational treatment will target marginal zone lymphoma (MZL) and follicular lymphoma (FL).
FDA pulls hydroxychloroquine for COVID-19, warns about other drug interaction
June 16, 2020
The agency revoked its emergency use authorization (EUA) for the drug, while warning about a dangerous interaction with remdesivir.
New pediatric HIV med available
June 15, 2020
The unique formulation is a dispersible tablet for children.
New antibiotic for hospital-acquired pneumonia available
June 05, 2020
The agency welcomes another option for serious bacterial infections.
Drug’s indication expanded to reduce heart attack, stroke risk
June 02, 2020
Brilinta is already approved to prevent atherothrombotic events in ASC.
Two metformin products recalled, more on the way
June 02, 2020
Immediately after the FDA said it found elevated levels of the carcinogenic ingredient N-nitrosodimethylamine (NDMA) in certain extended release (ER) metformin products, the first 2 major recalls are underway.
FDA approves med for severe malaria
May 28, 2020
IV artesunate is the only drug available in the U.S. to treat the disease.
Top 3 COVID-19 stories this week
May 19, 2020
FDA authorizes first stand-alone, at-home test, plus other top COVID-19 news stories.